Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Profit & Loss Account Balance

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
    Profit & Loss Account Balance ₹7,870 Cr₹9,457 Cr₹9,211 Cr₹7,234 Cr₹6,330 Cr

What is the latest Profit & Loss Account Balance ratio of GLENMARK PHARMACEUTICALS ?

The latest Profit & Loss Account Balance ratio of GLENMARK PHARMACEUTICALS is ₹7,870 Cr based on Mar2024 Consolidated results.
Year Profit & Loss Account Balance
Mar2024₹7,870 Cr
Mar2023₹9,457 Cr
Mar2022₹9,211 Cr
Mar2021₹7,234 Cr
Mar2020₹6,330 Cr

How is Profit & Loss Account Balance of GLENMARK PHARMACEUTICALS Trending?

Years Profit & Loss Account Balance % Change
Mar2024 ₹7,870 Cr
-16.78
Mar2023 ₹9,457 Cr
2.67
Mar2022 ₹9,211 Cr
27.33
Mar2021 ₹7,234 Cr
14.28
Mar2020 ₹6,330 Cr -

Compare Profit & Loss Account Balance of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses